Impact of intracellular ion channels on cancer development and progression

Roberta Peruzzo1, Lucia Biasutto2,3, Ildikò Szabò1,2

  • 1Department of Biology, University of Padua, Padua, Italy.

Insights

Ion channels are key targets in cancer research, contributing to tumor growth and spread. Targeting these "oncogenic" proteins, including intracellular ones, offers new therapeutic strategies for difficult-to-treat cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Aberrant ion channel expression is observed in cancer tissues.
  • Ion channels contribute to cancer hallmarks like proliferation, apoptosis resistance, and metastasis.
  • Both plasma membrane and intracellular channels are implicated in tumorigenesis.

Purpose of the Study:

  • To investigate the role of intracellular ion channels in cancer development and progression.
  • To explore the potential of targeting ion channels for novel cancer drug development.

Main Methods:

  • Literature review on ion channel function in cancer.
  • Analysis of aberrant ion channel expression in tumor cells.
  • Preclinical studies evaluating channel-targeting drugs in mouse models.

Main Results:

  • Ion channels are identified as "oncogenic" proteins driving cancer hallmarks.
  • Intracellular ion channels are increasingly recognized as significant targets in oncology.
  • Preclinical data show efficacy of ion channel-targeting drugs in reducing tumor burden.

Conclusions:

  • Targeting ion channels, particularly intracellular ones, presents a promising therapeutic avenue for cancer.
  • Further research into ion channel function and modulation is crucial for developing new anti-cancer drugs.
  • Ion channel modulators have demonstrated potential in preclinical cancer models, warranting clinical investigation.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
Ion Channels01:19

Ion Channels

The movement of ions like sodium, potassium, and calcium into and out of the cell is essential to maintain the electrochemical gradient in living cells. The ion channels—a class of membrane transport proteins—help maintain this ionic gradient for the smooth functioning of physiological activities such as maintaining cell size and volume, conducting nerve impulses, and gas and nutrient exchange.
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
92.5K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
8.9K
Non-gated Ion Channels01:24

Non-gated Ion Channels

4.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K